Skip to main content
Premium Trial:

Request an Annual Quote

Charles River Labs and GenOway to Co-Market Genetically Modified Research Models in Europe

NEW YORK, Nov. 23 (GenomeWeb News) - Charles River Laboratories and France-based GenOway will speed availability of genetically modified research models to their customers in Europe, the companies said this week.


Under the terms of the three-year agreement, Charles River Labs will market and promote GenOway's processes for developing research models, which include gene-expression and gene-inactivation techniques for mouse and rat models, the companies said.


Charles River Labs, which is based in Wilmington, Mass., said that it will market GenOway's technology to clients of its European Transgenic Services business. GenOway is based in Lyon.


The companies estimate that the agreement will result in a 45-percent shorter development time for such models while using the same budget as classical models, according to a statement.


Financial terms of the deal were not disclosed.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.